Mariner
ROIV icon

Mariner’s Roivant Sciences ROIV Stock Holding History

Mariner’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.6M Buy
202,316
+109,010
+117% +$2.8M 0.01% 1014
2025
Q4 		$2.02M Buy
93,306
+20,924
+29% +$413K ﹤0.01% 1499
2025
Q3 		$1.1M Buy
+72,382
New +$896K ﹤0.01% 1827
2025
Q2 		– Sell
-35,621
Closed -$359K – 3649
2025
Q1 		$359K Sell
35,621
-70,351
-66% -$761K ﹤0.01% 2473
2024
Q4 		$1.25M Buy
105,972
+20,299
+24% +$240K ﹤0.01% 1499
2024
Q3 		$989K Buy
85,673
+60,600
+242% +$690K ﹤0.01% 1611
2024
Q2 		$265K Sell
25,073
-334
-1% -$3.66K ﹤0.01% 2552
2024
Q1 		$268K Buy
25,407
+9,160
+56% +$98.8K ﹤0.01% 2541
2023
Q4 		$182K Buy
+16,247
New +$158K ﹤0.01% 2714

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.27B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return